Kennedy Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,261	Closed	-$460K	–	730
2018 Q1	$460K	Buy	+9,261	New	+$523K	0.01%	700
2017 Q4	–	Sell	-23,825	Closed	-$1.38M	–	743
2017 Q3	$1.38M	Sell	23,825 -13,047	-35%	-$682K	0.02%	641
2017 Q2	$1.82M	Buy	+36,872	New	+$1.7M	0.03%	600
2016 Q2	–	Sell	-9,049	Closed	-$405K	–	706
2016 Q1	$405K	Hold	9,049	–	–	0.01%	702
2015 Q4	$345K	Sell	9,049 -9,441	-51%	-$361K	0.01%	710
2015 Q3	$589K	Sell	18,490 -5,009	-21%	-$175K	0.01%	683
2015 Q2	$776K	Buy	23,499 +2,145	+10%	+$76.5K	0.01%	686
2015 Q1	$879K	Buy	21,354 +11,157	+109%	+$451K	0.02%	668
2014 Q4	$415K	Buy	+10,197	New	+$399K	0.01%	717
2014 Q1	–	Sell	-18,211	Closed	-$695K	–	740
2013 Q4	$695K	Buy	18,211 +3,211	+21%	+$99.1K	0.01%	676
2013 Q3	$358K	Buy	+15,000	New	+$337K	0.01%	723